Review



alinity s chagas  (Abbott Laboratories)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Abbott Laboratories alinity s chagas
    Recombinant antigens with the antigenic domains used in the Architect <t>Chagas</t> <t>and</t> <t>Alinity</t> s Chagas assays (Abbott Laboratories, Wiesbaden, Germany) in comparison with BioELISA (Werfen, Lliçà d’Amunt, Spain) and VirClia (Vircell, Granada, Spain). Dark gray boxes represent the antigenic domains in BioELISA, light gray boxes the antigenic domains in Architect Chagas and Alinity s Chagas, and black boxes the antigenic domains in VirClia. Most antigenic domains are included in multi-domain recombinant antigens, which are indicated within the boxes for each serological assay (TcF, FP10, FP6, FP3, and MACH).
    Alinity S Chagas, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/alinity+s+chagas/alinity+s+chagas/pmc11509444-62-20-31
    Average 90 stars, based on 1 article reviews
    alinity s chagas - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Assessment of Alinity s Chagas ® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain)"

    Article Title: Assessment of Alinity s Chagas ® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain)

    Journal: Life

    doi: 10.3390/life14101278

    Recombinant antigens with the antigenic domains used in the Architect Chagas and Alinity s Chagas assays (Abbott Laboratories, Wiesbaden, Germany) in comparison with BioELISA (Werfen, Lliçà d’Amunt, Spain) and VirClia (Vircell, Granada, Spain). Dark gray boxes represent the antigenic domains in BioELISA, light gray boxes the antigenic domains in Architect Chagas and Alinity s Chagas, and black boxes the antigenic domains in VirClia. Most antigenic domains are included in multi-domain recombinant antigens, which are indicated within the boxes for each serological assay (TcF, FP10, FP6, FP3, and MACH).
    Figure Legend Snippet: Recombinant antigens with the antigenic domains used in the Architect Chagas and Alinity s Chagas assays (Abbott Laboratories, Wiesbaden, Germany) in comparison with BioELISA (Werfen, Lliçà d’Amunt, Spain) and VirClia (Vircell, Granada, Spain). Dark gray boxes represent the antigenic domains in BioELISA, light gray boxes the antigenic domains in Architect Chagas and Alinity s Chagas, and black boxes the antigenic domains in VirClia. Most antigenic domains are included in multi-domain recombinant antigens, which are indicated within the boxes for each serological assay (TcF, FP10, FP6, FP3, and MACH).

    Techniques Used: Recombinant, Comparison, Serologic Assay

    Related Articles

    Biomarker Discovery:

    Article Title: Assessment of Alinity s Chagas ® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain)
    Article Snippet: Following its replacement of Architect Chagas in August 2020, the aim of the present study was to validate Alinity s Chagas ® , processed on the new Alinity s System ® (Abbott Laboratories, Wiesbaden, Germany), as a primary test for chronic CD diagnosis, applying an S/CO ratio ≥ 6.

    Article Title: In vitro diagnostic methods of Chagas disease in the clinical laboratory: a scoping review
    Article Snippet: However, it is worth noting that Abbott Laboratories’ FDA-approved assay Abbott PRISM was discontinued and replaced by Alinity S Chagas, another CMIA assay using the proteins FP3, FP6, FP10, and TcF, currently marketed for donor screening in Europe and the United States.

    Recombinant:

    Article Title: Assessment of Alinity s Chagas ® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain)
    Article Snippet: Following its replacement of Architect Chagas in August 2020, the aim of the present study was to validate Alinity s Chagas ® , processed on the new Alinity s System ® (Abbott Laboratories, Wiesbaden, Germany), as a primary test for chronic CD diagnosis, applying an S/CO ratio ≥ 6.

    Article Title: In vitro diagnostic methods of Chagas disease in the clinical laboratory: a scoping review
    Article Snippet: However, it is worth noting that Abbott Laboratories’ FDA-approved assay Abbott PRISM was discontinued and replaced by Alinity S Chagas, another CMIA assay using the proteins FP3, FP6, FP10, and TcF, currently marketed for donor screening in Europe and the United States.

    Comparison:

    Article Title: Assessment of Alinity s Chagas ® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain)
    Article Snippet: Following its replacement of Architect Chagas in August 2020, the aim of the present study was to validate Alinity s Chagas ® , processed on the new Alinity s System ® (Abbott Laboratories, Wiesbaden, Germany), as a primary test for chronic CD diagnosis, applying an S/CO ratio ≥ 6.

    Article Title: In vitro diagnostic methods of Chagas disease in the clinical laboratory: a scoping review
    Article Snippet: However, it is worth noting that Abbott Laboratories’ FDA-approved assay Abbott PRISM was discontinued and replaced by Alinity S Chagas, another CMIA assay using the proteins FP3, FP6, FP10, and TcF, currently marketed for donor screening in Europe and the United States.

    Serologic Assay:

    Article Title: Assessment of Alinity s Chagas ® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain)
    Article Snippet: Following its replacement of Architect Chagas in August 2020, the aim of the present study was to validate Alinity s Chagas ® , processed on the new Alinity s System ® (Abbott Laboratories, Wiesbaden, Germany), as a primary test for chronic CD diagnosis, applying an S/CO ratio ≥ 6.

    Article Title: In vitro diagnostic methods of Chagas disease in the clinical laboratory: a scoping review
    Article Snippet: However, it is worth noting that Abbott Laboratories’ FDA-approved assay Abbott PRISM was discontinued and replaced by Alinity S Chagas, another CMIA assay using the proteins FP3, FP6, FP10, and TcF, currently marketed for donor screening in Europe and the United States.

    Enzyme-linked Immunosorbent Assay:

    Article Title: Assessment of Alinity s Chagas ® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain)
    Article Snippet: Following its replacement of Architect Chagas in August 2020, the aim of the present study was to validate Alinity s Chagas ® , processed on the new Alinity s System ® (Abbott Laboratories, Wiesbaden, Germany), as a primary test for chronic CD diagnosis, applying an S/CO ratio ≥ 6.

    Article Title: In vitro diagnostic methods of Chagas disease in the clinical laboratory: a scoping review
    Article Snippet: However, it is worth noting that Abbott Laboratories’ FDA-approved assay Abbott PRISM was discontinued and replaced by Alinity S Chagas, another CMIA assay using the proteins FP3, FP6, FP10, and TcF, currently marketed for donor screening in Europe and the United States.

    Purification:

    Article Title: Assessment of Alinity s Chagas ® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain)
    Article Snippet: Following its replacement of Architect Chagas in August 2020, the aim of the present study was to validate Alinity s Chagas ® , processed on the new Alinity s System ® (Abbott Laboratories, Wiesbaden, Germany), as a primary test for chronic CD diagnosis, applying an S/CO ratio ≥ 6.

    Article Title: In vitro diagnostic methods of Chagas disease in the clinical laboratory: a scoping review
    Article Snippet: However, it is worth noting that Abbott Laboratories’ FDA-approved assay Abbott PRISM was discontinued and replaced by Alinity S Chagas, another CMIA assay using the proteins FP3, FP6, FP10, and TcF, currently marketed for donor screening in Europe and the United States.

    Diagnostic Assay:

    Article Title: Assessment of Alinity s Chagas ® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain)
    Article Snippet: Following its replacement of Architect Chagas in August 2020, the aim of the present study was to validate Alinity s Chagas ® , processed on the new Alinity s System ® (Abbott Laboratories, Wiesbaden, Germany), as a primary test for chronic CD diagnosis, applying an S/CO ratio ≥ 6.

    Article Title: In vitro diagnostic methods of Chagas disease in the clinical laboratory: a scoping review
    Article Snippet: However, it is worth noting that Abbott Laboratories’ FDA-approved assay Abbott PRISM was discontinued and replaced by Alinity S Chagas, another CMIA assay using the proteins FP3, FP6, FP10, and TcF, currently marketed for donor screening in Europe and the United States.

    Western Blot:

    Article Title: Assessment of Alinity s Chagas ® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain)
    Article Snippet: Following its replacement of Architect Chagas in August 2020, the aim of the present study was to validate Alinity s Chagas ® , processed on the new Alinity s System ® (Abbott Laboratories, Wiesbaden, Germany), as a primary test for chronic CD diagnosis, applying an S/CO ratio ≥ 6.

    Article Title: In vitro diagnostic methods of Chagas disease in the clinical laboratory: a scoping review
    Article Snippet: However, it is worth noting that Abbott Laboratories’ FDA-approved assay Abbott PRISM was discontinued and replaced by Alinity S Chagas, another CMIA assay using the proteins FP3, FP6, FP10, and TcF, currently marketed for donor screening in Europe and the United States.



    Similar Products

    alinity s chagas  (Abbott Laboratories)
    90
    Abbott Laboratories alinity s chagas
    Recombinant antigens with the antigenic domains used in the Architect <t>Chagas</t> <t>and</t> <t>Alinity</t> s Chagas assays (Abbott Laboratories, Wiesbaden, Germany) in comparison with BioELISA (Werfen, Lliçà d’Amunt, Spain) and VirClia (Vircell, Granada, Spain). Dark gray boxes represent the antigenic domains in BioELISA, light gray boxes the antigenic domains in Architect Chagas and Alinity s Chagas, and black boxes the antigenic domains in VirClia. Most antigenic domains are included in multi-domain recombinant antigens, which are indicated within the boxes for each serological assay (TcF, FP10, FP6, FP3, and MACH).
    Alinity S Chagas, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/alinity+s+chagas/alinity+s+chagas/pmc11509444-62-20-31
    Average 90 stars, based on 1 article reviews
    alinity s chagas - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Recombinant antigens with the antigenic domains used in the Architect Chagas and Alinity s Chagas assays (Abbott Laboratories, Wiesbaden, Germany) in comparison with BioELISA (Werfen, Lliçà d’Amunt, Spain) and VirClia (Vircell, Granada, Spain). Dark gray boxes represent the antigenic domains in BioELISA, light gray boxes the antigenic domains in Architect Chagas and Alinity s Chagas, and black boxes the antigenic domains in VirClia. Most antigenic domains are included in multi-domain recombinant antigens, which are indicated within the boxes for each serological assay (TcF, FP10, FP6, FP3, and MACH).

    Journal: Life

    Article Title: Assessment of Alinity s Chagas ® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain)

    doi: 10.3390/life14101278

    Figure Lengend Snippet: Recombinant antigens with the antigenic domains used in the Architect Chagas and Alinity s Chagas assays (Abbott Laboratories, Wiesbaden, Germany) in comparison with BioELISA (Werfen, Lliçà d’Amunt, Spain) and VirClia (Vircell, Granada, Spain). Dark gray boxes represent the antigenic domains in BioELISA, light gray boxes the antigenic domains in Architect Chagas and Alinity s Chagas, and black boxes the antigenic domains in VirClia. Most antigenic domains are included in multi-domain recombinant antigens, which are indicated within the boxes for each serological assay (TcF, FP10, FP6, FP3, and MACH).

    Article Snippet: Following its replacement of Architect Chagas in August 2020, the aim of the present study was to validate Alinity s Chagas ® , processed on the new Alinity s System ® (Abbott Laboratories, Wiesbaden, Germany), as a primary test for chronic CD diagnosis, applying an S/CO ratio ≥ 6.

    Techniques: Recombinant, Comparison, Serologic Assay